Research Article

Rehabilitation Therapy Utilization in Patients with Parkinson’s Disease in Korea

Table 3

Rehabilitation therapy use according to patients’ characteristics in the period of 2013–2015.

CharacteristicsAll typesPTOTST
AOR95% CIAOR95% CIAOR95% CIAOR95% CI

Sex
MaleRef.Ref.Ref.Ref.
Female1.6681.274–2.1821.7551.338–2.3011.2140.868–1.6980.8940.493–1.619

Age (y)
0–59Ref.Ref.Ref.Ref.
60–692.8061.550–5.0773.1391.703–5.7852.4831.144–5.3914.130.872–19.550
70–794.0532.310–7.1134.5762.557–8.1873.4131.635–7.1223.5660.782–16.260
80+3.7732.068–6.8844.0412.172–7.5163.2461.475–7.1422.990.585–15.293

Income
LowRef.Ref.Ref.Ref.
Middle1.0950.767–1.5651.1250.786–1.6100.9650.614–1.5161.0330.411–2.598
High1.4421.018–2.0451.4120.994–2.0061.2190.791–1.8792.0660.902–4.736

Region of residence
Seoul/IncheonRef.Ref.Ref.Ref.
Gyeonggi/Gangwon0.8250.571–1.1920.8520.590–1.2371.1060.696–1.7570.8870.411–1.913
Busan/Daegu/Ulsan/Gyeongsang0.9210.639–1.3270.9540.661–1.3771.270.807–1.9990.4650.189–1.145
Daejeon/Sejong/Chungcheong0.8790.535–1.4450.9040.548–1.4891.0340.546–1.9571.1170.404–3.090
Gwangju/Jeolla/Jeju0.8060.525–1.2390.8710.566–1.3400.9520.546–1.6610.8140.315–2.106

Comorbidities
NoRef.Ref.Ref.Ref.
Yes1.4570.976–2.1751.3970.935–2.0871.5460.977–2.4461.7580.821–3.767

Disability grade
NoneRef.Ref.Ref.Ref.
Mild to moderate (3–6)21.486–2.6902.0791.544–2.8002.561.802–3.6352.4531.295–4.646
Severe (1-2)2.9391.815–4.7582.7381.692–4.4301.81.000–3.2393.0781.214–7.802

Levodopa-equivalent dose
<200Ref.Ref.Ref.Ref.
≥200, <4001.0160.703–1.4701.0760.741–0.9030.9510.581–1.5572.2840.638–8.176
≥400, <6001.3380.882–2.0301.3760.903–2.0961.2340.715–2.1293.1030.828–11.625
≥600, <8001.6470.994–2.7301.7681.064–2.9401.3440.706–2.5602.9640.695–12.642
≥8004.052.484–6.6013.9522.423–6.4463.7922.174–6.6169.4382.601–34.253

PT, physical therapy; OT, occupational therapy; ST, swallowing therapy.